Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenoldopam and renal failure after cardiac surgery
2008-002077-12Phase 4Active
- Sponsor
- Azienda Ospedaliera di Perugia
- Start
- May 2012
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fenoldopam in acute kidney failure (AKF) (2 arms), sponsored by Azienda Ospedaliera di Perugia. Primary endpoint: Need for renal replacement therapy. Started May 2012; status: active.
02
Drugs
fenoldopam
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on 2008-002077-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002077-12.